Chief financial officer

Plains All American Announces Officer Appointments

Retrieved on: 
Wednesday, January 4, 2023
Business administration, Communication, Government, Acton School of Business, Plains All American Pipeline, Sustainability, Research, Business, Piper, United States Senate Agriculture Subcommittee on Commodities, Risk Management, and Trade, University, Public affairs, Business development, Scotiabank, Louisiana State University, Political science, Chief financial officer, Master of Business Administration, PAA, Equity capital markets, Senior, Management, Plain, Entrepreneurship, Economics, Lamoreaux

HOUSTON, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA ) and Plains GP Holdings (Nasdaq: PAGP ) today announced the appointment of Blake Fernandez as Vice President, Investor Relations.

Key Points: 
  • HOUSTON, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA ) and Plains GP Holdings (Nasdaq: PAGP ) today announced the appointment of Blake Fernandez as Vice President, Investor Relations.
  • “Blake brings extensive energy finance and equity research experience, and we welcome him to the Plains team.
  • Adding dedicated officer-level resources to these critical areas enables us to further advance our relationships with the financial community while continuing to grow key stakeholder engagement activities,” stated Willie Chiang, Chairman and CEO of Plains All American.
  • He was responsible for starting and advancing Plains’ Communications, Sustainability and Government Relations practices along with launching the Plains All American Political Action Committee.

Cystic Fibrosis Foundation Announces Irena Barisic as Next Chief Operating and Financial Officer

Retrieved on: 
Tuesday, December 6, 2022
Research, Philanthropy, Health, Fund Raising, General Health, Other Philanthropy, Foundation, Other Science, Science, Valencia CF Foundation, Cystic fibrosis, Policy, Conditional sentence, Administrative Office of the United States Courts, MD, FP, Audit, Bangladesh Technical Education Board, Contract management, Research, Advisory Council, Human resources, Cystic Fibrosis Foundation, Financial management, Grant (money), AFP, Brookings Institution, Chief financial officer, Management, Operation

Today, the Cystic Fibrosis Foundation announced that Irena Barisic has been appointed the next Executive Vice President, Chief Operating and Financial Officer.

Key Points: 
  • Today, the Cystic Fibrosis Foundation announced that Irena Barisic has been appointed the next Executive Vice President, Chief Operating and Financial Officer.
  • Irena has made significant contributions to strengthening our organization, from expertly managing our financial resources to helping us accelerate our progress and best serve people with cystic fibrosis, said Michael Boyle, MD, president and CEO of the Cystic Fibrosis Foundation.
  • As Chief Operating and Financial Officer, Barisic will oversee the Foundations day-to-day operations with broad responsibility and oversight of operating and financial functions, and serve as a strategic advisor to the president and CEO.
  • The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis.

Torrid Holdings Inc. Investors: Please contact the Portnoy Law Firm to recover your losses, January 17, 2023 deadline

Retrieved on: 
Wednesday, November 30, 2022
COVID-19, Risk, Chief financial officer, CURV, NYSE, Government, IPO, Torrid, Security (finance), Pharmaceutical industry, Delta

LOS ANGELES, Nov. 30, 2022 (GLOBE NEWSWIRE) -- ​The Portnoy Law Firm advises Torrid Holdings Inc. (“Torrid” or “the Company”) (NYSE: CURV) investors that a lawsuit filed on behalf of investors that purchased securities traceable to the Company’s July 2021 initial public offering. Torrid investors are encouraged to contact the firm to discuss their legal rights.

Key Points: 
  • Torrid investors are encouraged to contact the firm to discuss their legal rights.
  • Investors are encouraged to contact attorney Lesley F. Portnoy ,by phone 844-767-8529 or email : [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com .
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

Option3 Sells Dark Cubed Position to Celerium

Retrieved on: 
Wednesday, October 19, 2022
Dark, Marketing, Advisory Council, Fund, Pleasure, MSP, Government, White House, C2, Super Mario, Lehman Brothers, Intelligence, Chief financial officer, White, CIA, Partnership, United States Department of Defense, National Infrastructure Advisory Council, Punjab Information Technology Board, Industry, Department, Department of Defence, Board, Ecosystem, Risk management, U.S. Department of Defense Strategy for Operating in Cyberspace, Federation, CISO, CIO, Managed services, Solution, Weapon, Technology, Thakur

NEW YORK, Oct. 19, 2022 /PRNewswire/ -- Option3, a specialist cybersecurity private equity firm that combines a heritage in the national security community with decades of expertise in the investment industry, announced today that it recently sold its entire investment in Dark Cubed, an automated network security solution serving small and medium- sized businesses (SMBs), to Celerium, a leader in innovative active cyber defense solutions.

Key Points: 
  • By delivering automated data-driven decision making at a low monthly price point, Dark Cubed created its own category in the market, consequently not competing with vendors in the firewall and threat intelligence space."
  • "It was a pleasure working with Vince and the team," said Lisa Donnan, Operating Partner and former Board Member at Dark Cubed.
  • Donnan, along with one other Option3 representative, resigned from the Dark Cubed board earlier this month when the private equity firm sold its entire position and ended its role at the company.
  • "We were invested in Dark Cubed for only two years, a brief period for us.

Veteran Chief Information Security Officer, Rich Armour, Joins Technology Board of Cybersecurity Private Equity Specialist, Option3

Retrieved on: 
Friday, September 30, 2022
Fund, Dell, Department, CIA, Lehman Brothers, CIO, National Infrastructure Advisory Council, NEW, Punjab Information Technology Board, Growth, Review, Armour, Industry, C2, Investment, General Motors, Department of Defence, Hewlett-Packard, Air force, Ecosystem, Insurance, Information technology, Chief financial officer, CISO, Marketing, Advisory Council, Risk management, United, Former, Financial services, Technology

NEW YORK, Sept. 30, 2022 /PRNewswire/ -- Option3, a specialist cybersecurity private equity firm that combines a heritage in the national security community with decades of expertise in the investment industry, announced today that industry veteran Rich Armour has joined its Technology Board. In this role, Armour will offer insight and strategic direction on the firm's investment strategy. This appointment comes at a time of growth for Option3 with its C2 mid-market Cybersecurity Private Equity fund as well as focused investments in priority areas that span from insurance to military contracting.

Key Points: 
  • This appointment comes at a time of growth for Option3 with its C2 mid-market Cybersecurity Private Equity fund as well as focused investments in priority areas that span from insurance to military contracting.
  • Armour also served in a similar global cyber role as Information Technology Director for Dell Computers from 2000 to 2005.
  • "He joins us at an important time for Option3 as we set strategies and review investments for our C2 cyber mid-market fund.
  • The Fund will leverage the C-suite operational experience of the Option3 team including Chief Financial, Marketing, Technology, and Risk Management positions.

USAA Names New SVP in Chief Legal Office

Retrieved on: 
Monday, September 12, 2022
Employment, USAA, Durrani, Twitter, Journalism, Sale, City, Privacy, Acquisition, Counsel, Loyola University, Allstate, Facebook, Technology, Veteran, ESS, Chief financial officer, Leadership, Insurance, Retirement, Baron Waqa, Master of Science, Champaign County, Illinois, SAN, University, Management, Science, Esurance

SAN ANTONIO, Sept. 12, 2022 /PRNewswire/ -- USAA announced Waqas Durrani has been promoted to senior vice president, Enterprise Shared Services (ESS) Counsel in USAA's Chief Legal Office. In this role, Durrani will lead teams supporting technology and transactions, privacy and data security, labor and employment, and USAA's Chief Financial Office. He previously led the technology and transactions team as vice president and will report to USAA Chief Legal Officer Bob Johnson.

Key Points: 
  • SAN ANTONIO, Sept. 12, 2022 /PRNewswire/ -- USAA announced Waqas Durranihas been promoted to senior vice president, Enterprise Shared Services (ESS) Counsel in USAA's Chief Legal Office.
  • In this role, Durrani will lead teams supporting technology and transactions, privacy and data security, labor and employment, and USAA's Chief Financial Office.
  • He previously led the technology and transactions team as vice president and will report to USAA Chief Legal Officer Bob Johnson.
  • For more information about USAA, follow us on Facebook or Twitter (@USAA), or visit usaa.com.

Jason Cole, Chief Strategy and Financial Officer, to Depart bluebird bio This Fall

Retrieved on: 
Monday, September 12, 2022
General Health, Health, Other Health, Chief financial officer, Thalassemia, General counsel, Culture, CFO, Safety, Bluebird bio, Bluebird, Disease, Sumathi Best Television Current Reporting Award, Principal, Intention, Company, Private Securities Litigation Reform Act, Industry, Forward-looking statement, U.S. Securities and Exchange Commission, Patient, Sickle cell disease, Risk, CEO, Finance, Goal, General officer, Bird, NASDAQ, Research, Lists of diseases, Security (finance), Â, View, Management, Risk management, Pharmaceutical industry

(NASDAQ: BLUE) today announced that Jason Cole, Chief Strategy and Financial Officer, plans to leave bluebird bio to pursue new career opportunities.

Key Points: 
  • (NASDAQ: BLUE) today announced that Jason Cole, Chief Strategy and Financial Officer, plans to leave bluebird bio to pursue new career opportunities.
  • Throughout his 8.5 years at bluebird, Mr. Cole has held multiple roles including General Counsel/Chief Legal Officer (2014-2019), Chief Operating & Legal Officer (2019-2021) and Chief Business Officer (2021-2022).
  • In March 2022, Mr. Cole was appointed Chief Strategy and Financial Officer at a critical juncture for the company.
  • Jason is the quintessential bluebird with a deep commitment to the patients and families we aspire to treat, to our business, and to the culture that makes bluebird so unique, said Andrew Obenshain, CEO, bluebird bio.

LCM Partners appoints Roger Kibble-White as Group CFO

Retrieved on: 
Thursday, September 8, 2022
JPMorgan Chase, Fidelity International, Team, Board, Treasury, Chief financial officer, KPMG, CFO, Chief investment officer, Group, Industry, Growth, Management

LONDON, Sept. 8, 2022 /PRNewswire/ -- LCM Partners, a leading European Alternatives Investment Manager, today announced that it has appointed Roger Kibble-White as the Group CFO.

Key Points: 
  • LONDON, Sept. 8, 2022 /PRNewswire/ -- LCM Partners, a leading European Alternatives Investment Manager, today announced that it has appointed Roger Kibble-White as the Group CFO.
  • Roger has significant experience in the investment industry as a CFO and joins from Fidelity International, a leading fund manager with over $600bn of assets under manager, where he was the Group Finance Director.
  • Prior to this role, Roger spent 16 years at JP Morgan Chase where he held several positions including Global CFO for Asset Management and CFO for EMEA Treasury and the Chief Investment Office.
  • As part of the senior leadership team Roger will work closely with the Board to help build the business as the company's scale and geographic reach grows.

LCM Partners appoints Roger Kibble-White as Group CFO

Retrieved on: 
Thursday, September 8, 2022
JPMorgan Chase, Fidelity International, Team, Board, Treasury, Chief financial officer, KPMG, CFO, Chief investment officer, Group, Industry, Growth, Management

LONDON, Sept. 8, 2022 /PRNewswire/ -- LCM Partners, a leading European Alternatives Investment Manager, today announced that it has appointed Roger Kibble-White as the Group CFO.

Key Points: 
  • LONDON, Sept. 8, 2022 /PRNewswire/ -- LCM Partners, a leading European Alternatives Investment Manager, today announced that it has appointed Roger Kibble-White as the Group CFO.
  • Roger has significant experience in the investment industry as a CFO and joins from Fidelity International, a leading fund manager with over $600bn of assets under manager, where he was the Group Finance Director.
  • Prior to this role, Roger spent 16 years at JP Morgan Chase where he held several positions including Global CFO for Asset Management and CFO for EMEA Treasury and the Chief Investment Office.
  • As part of the senior leadership team Roger will work closely with the Board to help build the business as the company's scale and geographic reach grows.

Olema Oncology to Present at H.C. Wainwright 24th Annual Global Investment Conference

Retrieved on: 
Tuesday, September 6, 2022
Investor, Chief financial officer, GLOBE, Conference, SAN, SERD, Patient, Pharmaceutical industry

SAN FRANCISCO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (Olema, Olema Oncology or the Company, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for womens cancers, today announced that Shane Kovacs, Chief Operating and Financial Officer, will participate in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14, 2022, at 2:30 p.m.

Key Points: 
  • SAN FRANCISCO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (Olema, Olema Oncology or the Company, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for womens cancers, today announced that Shane Kovacs, Chief Operating and Financial Officer, will participate in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14, 2022, at 2:30 p.m.
  • A live webcast of the fireside chat and the corporate presentation may be accessed under the Investors & Media section of Olemas website ( www.olema.com ) and will be archived for 14 days.
  • Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for womens cancers.
  • Olema is headquartered in San Francisco and has operations in Cambridge, Massachusetts.